P5421Is soluble supression of tumorigenicity (sST2) a new biomarker in patients with right ventricular failure due to pulmonary hypertension?
Banaszkiewicz, M., Darocha, S., Pietrasik, A., Norwa, J., Dobosiewicz, A., Kepski, J., Florczyk, M., Manczak, R., Torbicki, A., Kurzyna, M.
Published in European heart journal (01.08.2017)
Published in European heart journal (01.08.2017)
Get full text
Journal Article
P2600Replacement sildenafil by riociugat in patients with inoperable or persistent chronic thromboembolic pulmonary hypertension improves exercise capacity and hemodynamics
Darocha, S., Banaszkiewicz, M., Pietrasik, A., Dobosiewicz, A., Florczyk, M., Manczak, R., Pilka, M., Norwa, J., Kepski, J., Wieteska, M., Szmit, S., Torbicki, A., Kurzyna, M.
Published in European heart journal (01.08.2017)
Published in European heart journal (01.08.2017)
Get full text
Journal Article
P2604A long-term outcome of patients with chronic thromboembolic pulmonary hypertension treated with different methods
Darocha, S., Pietura, R., Pietrasik, A., Dobosiewicz, A., Florczyk, M., Pilka, M., Norwa, J., Manczak, R., Wieteska, M., Banaszkiewicz, M., Szmit, S., Biederman, A., Torbicki, A., Kurzyna, M.
Published in European heart journal (01.08.2017)
Published in European heart journal (01.08.2017)
Get full text
Journal Article